Douglas M. Evans
About
In The Last Decade
Douglas M. Evans
11 papers receiving 287 citations
Peers
Comparison fields: 5 of 62
- Surgery 105
- Dermatology 80
- Oncology 75
- Cancer Research 73
- Pathology and Forensic Medicine 51
Countries citing papers authored by Douglas M. Evans
This map shows the geographic impact of Douglas M. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas M. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas M. Evans more than expected).
Fields of papers citing papers by Douglas M. Evans
This network shows the impact of papers produced by Douglas M. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas M. Evans. The network helps show where Douglas M. Evans may publish in the future.
Co-authorship network of co-authors of Douglas M. Evans
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas M. Evans. A scholar is included among the top collaborators of Douglas M. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas M. Evans. Douglas M. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 18 | |
| 3 | 16 | |
| 4 | 31 | |
| 5 | 18 | |
| 6 | 85 | |
| 7 | Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor. | 20 |
| 8 | 84 | |
| 9 | 11 | |
| 10 | The role of bone and liver scans in surveying patients with breast cancer for metastatic disease. | 4 |
| 11 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.